UnitedHealth Group stock (US91324P1021): Q1 2026 earnings frame latest NYSE trading

UnitedHealth Group shares on the NYSE hovered around USD 380 in recent trading as investors continued to digest the health insurer's Q1 2026 results and outlook for its UnitedHealthcare and Optum businesses.

UnitedHealth Group shares in the United States traded around the mid-USD 380 range on the New York Stock Exchange on 06/02/2026, with MarketBeat data showing a last price close to USD 380.03 and only a marginal move on the day as investors weighed the latest quarterly figures and guidance commentary for the health insurer's core operations.MarketBeat as of 06/02/2026

In its home market of the United States, UnitedHealth Group remains a heavyweight component of the managed health care segment, and the Q1 2026 earnings release published in April 2026 provided the most recent detailed snapshot of performance for both the UnitedHealthcare insurance arm and the Optum health-services franchise, which together continue to shape sentiment around the stock.UnitedHealth Group investor relations as of 04/2026

The stock traded at roughly USD 380.03 on 06/02/2026 on the NYSE, according to MarketBeat data, reflecting a modest decline of about 0.1 percent on the session but leaving the company firmly within a range that has prevailed since the Q1 2026 numbers were absorbed by the market.MarketBeat as of 06/02/2026

As of: 02.06.2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: UnitedHealth Group
• Sector/industry: Managed health care and health services
• Headquarters/country: Minnetonka, United States
• Core markets: Commercial and government health insurance and health services in the United States, with selected international activities
• Key revenue drivers: Premiums from UnitedHealthcare health plans and fee-based services from Optum across health care delivery, pharmacy benefits and data analytics
• Home exchange/listing venue: New York Stock Exchange (UNH)
• Trading currency: USD

UnitedHealth Group: core business model

UnitedHealth Group combines a large US-centered health insurance franchise under UnitedHealthcare with the Optum platform for health services, data analytics and pharmacy benefits, with both units primarily generating revenue from insurance premiums and contracted health services volumes.

Latest quarterly results for UnitedHealth Group at a glance

UnitedHealth Group's most recent set of detailed financials comes from its Q1 2026 earnings report, in which the company outlined how actions taken across UnitedHealthcare and Optum supported first-quarter performance and informed its outlook for the remainder of 2026.UnitedHealth Group Q1 2026 results as referenced 06/01/2026

According to the Q1 2026 communication, management highlighted the contribution from the diversified mix of commercial, Medicare and Medicaid plans at UnitedHealthcare as well as ongoing growth initiatives at Optum, providing the key financial benchmarks and qualitative commentary that investors are using as a framework while the stock trades near USD 380 on the NYSE.UnitedHealth Group investor relations as of 04/2026

Conclusion

With UnitedHealth Group stock trading close to USD 380 on the NYSE, the Q1 2026 earnings release remains the key reference point for how the UnitedHealthcare and Optum businesses are tracking against management's expectations. The combination of stable trading in the United States and the latest quarterly disclosure gives investors a structured basis for assessing how upcoming quarters might influence the share price.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.